Our work supported the promoting effect of GBM-serum-EVs on the proliferative and invasive phenotypes and TMZ resistance of GBM cells by regulating the HOTAIR/miR-526b-3p/EVA1 axis. The gene discussed is MPZL2; the disease is glioblastoma.